car-t

The Scientist’s Creative Services Team and Sino Biological | May 10, 2023 | 4 min read

From early target discovery to preclinical development stages, researchers explore novel strategies for effective cell therapies in cancer treatment.

The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific | Sep 7, 2021 | 2 min read

Automated counterflow centrifugation systems accelerate cell therapy workflow processes while maintaining cell yields and efficacy.

The Scientist’s Creative Services Team | Aug 27, 2020 | 1 min read

Download this eBook to take a closer look at past efforts, modern challenges, and future advances!

Katarina Zimmer | Jan 22, 2018 | 2 min read

Pharmaceutical giant Sanofi to take over hemophilia drugmaker Biovertiv, while Celgene will buy cancer drugmaker Juno Therapeutics.

Diana Kwon | Jun 5, 2017 | 2 min read

The results of two small clinical trials show that the immunotherapy is effective for multiple myeloma patients, at least in the near term.

Ben Andrew Henry | Sep 6, 2016 | 1 min read

The company has shuttered its experimental cell and gene cancer therapy unit, firing more than 100 researchers.

Kerry Grens | Jul 8, 2016 | 3 min read

Juno Therapeutics asks the US Food and Drug Administration for permission to restart the CAR-T experiments without chemotherapy.

Kerry Grens | Mar 16, 2016 | 2 min read

Corrections give belated credit for immunotherapy; mosquitoes have been bugging us long before Zika; the bright side of irreproducibility